Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Baseline distribution and conditional size

S Senn

    Journal of Biopharmaceutical Statistics
    |September 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    This study analyzes how baseline distribution affects hypothesis testing in two-group trials, offering analytical results that can replace simulation methods for treatment effect significance tests.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of humeral head osteochondrosis in the Greater Swiss Mountain dog and the Border Collie in Switzerland.

    Schweizer Archiv fur Tierheilkunde·2016
    Same author

    A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial).

    Revista portuguesa de pneumologia·2015
    Same author

    Statisticians and pharmacokineticists: what they can still learn from each other.

    Clinical pharmacology and therapeutics·2010
    Same author

    Ethical considerations concerning treatment allocation in drug development trials.

    Statistical methods in medical research·2002
    Same author

    Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction.

    Pulmonary pharmacology & therapeutics·2002
    Same author

    Screening for breast cancer with mammography.

    Lancet (London, England)·2002
    Same journal

    Correction.

    Journal of biopharmaceutical statistics·2026
    Same journal

    Leveraging external controls in clinical trials: estimands, estimation, assumptions.

    Journal of biopharmaceutical statistics·2026
    Same journal

    Special issue of nonclinical statistics in regulatory applications guest editors' notes.

    Journal of biopharmaceutical statistics·2026
    Same journal

    Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

    Journal of biopharmaceutical statistics·2026
    Same journal

    Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

    Journal of biopharmaceutical statistics·2026
    Same journal

    Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

    Journal of biopharmaceutical statistics·2026
    See all related articles

    Area of Science:

    • Biostatistics
    • Clinical Trial Design
    • Statistical Inference

    Background:

    • The performance of hypothesis tests in clinical trials is influenced by the distribution of baseline characteristics.
    • Previous research often relied on simulation studies to assess the impact of baseline distributions on test performance.
    • This study focuses on two-group trial designs, a common framework in clinical research.

    Discussion:

    • The conditional size of significance tests (Type I error rate) is critically examined under varying baseline distributions.
    • Analytical results provide a direct method to understand test behavior without the need for computationally intensive simulations.
    • The findings are applicable to a range of hypothesis and significance tests used for treatment evaluation.

    Key Insights:

    Related Experiment Videos

    • Baseline distribution significantly impacts the conditional size of hypothesis tests in two-group trials.
    • Analytical solutions are presented as a viable and potentially more efficient alternative to simulation-based assessments.
    • Understanding these effects is crucial for accurate interpretation of treatment efficacy.

    Outlook:

    • The presented analytical framework can enhance the design and interpretation of future clinical trials.
    • Further research could extend this analysis to more complex trial designs or different types of endpoints.
    • This work provides a foundation for developing more robust statistical methods in clinical research.